162 related articles for article (PubMed ID: 33743147)
1. Value of ultrafast and standard dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the presence and extension of residual disease after neoadjuvant chemotherapy in breast cancer.
Kato E; Mori N; Mugikura S; Sato S; Ishida T; Takase K
Jpn J Radiol; 2021 Aug; 39(8):791-801. PubMed ID: 33743147
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.
Zhou J; Li G; Sheng F; Qiao P; Zhang H; Xing X
Acta Radiol; 2016 May; 57(5):529-37. PubMed ID: 26231950
[TBL] [Abstract][Full Text] [Related]
3. Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer after Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype.
Honda M; Kataoka M; Iima M; Ota R; Ohashi A; Kishimoto AO; Miyake KK; Nickel MD; Yamada Y; Toi M; Nakamoto Y
Tomography; 2022 Jun; 8(3):1522-1533. PubMed ID: 35736873
[TBL] [Abstract][Full Text] [Related]
4. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI.
Cao Y; Wang X; Li L; Shi J; Zeng X; Huang Y; Chen H; Jiang F; Yin T; Nickel D; Zhang J
Diagn Interv Imaging; 2023 Dec; 104(12):605-614. PubMed ID: 37543490
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy.
Kim SY; Cho N; Park IA; Kwon BR; Shin SU; Kim SY; Lee SH; Chang JM; Moon WK
Radiology; 2018 Nov; 289(2):327-334. PubMed ID: 30152744
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
7. Bilateral asymmetry of quantitative parenchymal kinetics at ultrafast DCE-MRI predict response to neoadjuvant chemotherapy in patients with HER2+ breast cancer.
Ren Z; Pineda FD; Howard FM; Fan X; Nanda R; Abe H; Kulkarni K; Karczmar GS
Magn Reson Imaging; 2023 Dec; 104():9-15. PubMed ID: 37611646
[TBL] [Abstract][Full Text] [Related]
8. Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.
Onishi N; Sadinski M; Hughes MC; Ko ES; Gibbs P; Gallagher KM; Fung MM; Hunt TJ; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
Breast Cancer Res; 2020 May; 22(1):58. PubMed ID: 32466799
[TBL] [Abstract][Full Text] [Related]
9. Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging.
Han X; Yang H; Jin S; Sun Y; Zhang H; Shan M; Cheng W
Cancer Med; 2023 Jan; 12(2):1389-1398. PubMed ID: 35822639
[TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
[TBL] [Abstract][Full Text] [Related]
11. Ultrafast dynamic contrast-enhanced breast MRI: association with pathologic complete response in neoadjuvant treatment of breast cancer.
Kim JH; Park VY; Shin HJ; Kim MJ; Yoon JH
Eur Radiol; 2022 Jul; 32(7):4823-4833. PubMed ID: 35064805
[TBL] [Abstract][Full Text] [Related]
12. Nonmass Enhancement Breast Lesions: Diagnostic Performance of Kinetic Assessment on Ultrafast and Standard Dynamic Contrast-Enhanced MRI in Comparison With Morphologic Evaluation.
Mori N; Sheth D; Abe H
AJR Am J Roentgenol; 2020 Aug; 215(2):511-518. PubMed ID: 32452698
[No Abstract] [Full Text] [Related]
13. The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients.
Lee SJ; Ko KH; Jung HK; Koh JE; Park AY
Eur J Radiol; 2020 Mar; 124():108841. PubMed ID: 31981877
[TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
Jun W; Cong W; Xianxin X; Daqing J
Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
[TBL] [Abstract][Full Text] [Related]
15. Prospective Evaluation of Ultrafast Breast MRI for Predicting Pathologic Response after Neoadjuvant Therapies.
Ramtohul T; Tescher C; Vaflard P; Cyrta J; Girard N; Malhaire C; Tardivon A
Radiology; 2022 Dec; 305(3):565-574. PubMed ID: 35880977
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.
Li Z; Li J; Lu X; Qu M; Tian J; Lei J
Eur J Radiol; 2021 Oct; 143():109931. PubMed ID: 34492627
[TBL] [Abstract][Full Text] [Related]
17. Ultrafast Dynamic Contrast-Enhanced Breast MRI: Kinetic Curve Assessment Using Empirical Mathematical Model Validated with Histological Microvessel Density.
Mori N; Abe H; Mugikura S; Takasawa C; Sato S; Miyashita M; Mori Y; Pineda FD; Karczmar GS; Tamura H; Takahashi S; Takase K
Acad Radiol; 2019 Jul; 26(7):e141-e149. PubMed ID: 30269956
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative evaluation of pathologic response in patients with breast cancer by dynamic contrast-enhanced magnetic resonance imaging].
Zhang XP; Li J; Sun YS; Cao K; Tang L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):98-103. PubMed ID: 18361063
[TBL] [Abstract][Full Text] [Related]
19. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
Abramson RG; Li X; Hoyt TL; Su PF; Arlinghaus LR; Wilson KJ; Abramson VG; Chakravarthy AB; Yankeelov TE
Magn Reson Imaging; 2013 Nov; 31(9):1457-64. PubMed ID: 23954320
[TBL] [Abstract][Full Text] [Related]
20. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
